Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
|ClinicalTrials.gov Identifier: NCT01159613|
Recruitment Status : Completed
First Posted : July 9, 2010
Last Update Posted : July 9, 2010
|Condition or disease||Intervention/treatment|
|Chronic Hepatitis C Viral Infection||Other: Responders Other: Non Responders|
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection.
Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR).
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?|
|Study Start Date :||April 2008|
|Actual Primary Completion Date :||October 2008|
|Actual Study Completion Date :||January 2009|
Other: Non Responders
- sustained viral response [ Time Frame: 72 weeks ]achieving SVR
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01159613
|Ziv medical center liver unit|
|Safed, Israel, Israel|